> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA Withdraws Watson Generic Oxycodone/Ibuprofen
- URL: https://www.fdaweb.com/fda-withdraws-watson-generic-oxycodone-ibuprofen/
- Published: 2020-07-31T12:00:00.000Z
- Updated: 2026-09-14T16:23:25.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5147327

*Federal Register* notice: FDA is withdrawing approval of a Watson Pharmaceutical ANDA for oxycodone hydrochloride and ibuprofen tablets, indicated for relieving pain. The basis for the withdrawal is that Watson has repeatedly failed to submit the required bioequivalence data necessary to demonstrate the bioequivalence of its drug product. To view the notice, click [here](https://s3.amazonaws.com/public-inspection.federalregister.gov/2020-16784.pdf?ref=fdaweb.com).